Study designs: all MPD measure sets of study design type ctrltrt

ctrltrt = control group vs. treated group

Select table page: First Prev Next Last
   FILTER RESULTS BY:
Data set Clear All
Procedure / Protocol Clear All
Drug or Challenge Clear All
Panel Clear All
Sex Clear All
Data set MPD ID Procedure / Protocol Drug or Challenge Phenotype Measure Panel No. of Strains Sex Age Sample Size (Avg) Year
    Cheverud1 17815 body weight high-fat diet growth rate, age 4 to 10wks   [g/wk]     post-weaning (4-10wks):    control diet    high-fat diet LGXSM w/par 16 both N=8 2004
    Cheverud1 17816 body weight high-fat diet growth rate, age 11 to 20 wks   [g/wk]     adult (11-20wks):    control diet    high-fat diet LGXSM w/par 15 both N=8 2004
    Cheverud1 17820 organ weights high-fat diet kidney weight (both) as percent of body weight   [%]     control diet    high-fat diet LGXSM w/par 16 both 20-30wks N=8 2004
    Cheverud1 17821 organ weights high-fat diet heart weight as percent of body weight   [%]     control diet    high-fat diet LGXSM w/par 16 both 20-30wks N=8 2004
    Cheverud1 17822 organ weights high-fat diet spleen weight as percent of body weight   [%]     control diet    high-fat diet LGXSM w/par 16 both 20-30wks N=8 2004
    Cheverud1 17823 organ weights high-fat diet liver weight as percent of body weight   [%]     control diet    high-fat diet LGXSM w/par 16 both 20-30wks N=8 2004
    Cheverud1 17824 fat pad weights high-fat diet gonadal fat pad weight   [g]     control diet    high-fat diet LGXSM w/par 16 both 20-30wks N=8 2004
    Cheverud1 17825 fat pad weights high-fat diet perirenal fat pad weight   [g]     control diet    high-fat diet LGXSM w/par 16 both 20-30wks N=8 2004
    Cheverud1 17826 fat pad weights high-fat diet mesenteric fat pad weight   [g]     control diet    high-fat diet LGXSM w/par 16 both 20-30wks N=8 2004
    Cheverud1 17827 fat pad weights high-fat diet inguinal fat pad weight   [g]     control diet    high-fat diet LGXSM w/par 16 both 20-30wks N=8 2004
    Cheverud1 17828 fat pad weights high-fat diet total fat pad weight   [g]     control diet    high-fat diet LGXSM w/par 16 both 20-30wks N=8 2004
    Cheverud1 17829 fat pad weights high-fat diet gonadal fat pad weight as pecent of body weight   [%]     control diet    high-fat diet LGXSM w/par 16 both 20-30wks N=8 2004
    Cheverud1 17830 fat pad weights high-fat diet perirenal fat pad weight as pecent of body weight   [%]     control diet    high-fat diet LGXSM w/par 16 both 20-30wks N=8 2004
    Cheverud1 17831 fat pad weights high-fat diet mesenteric fat pad weight as pecent of body weight   [%]     control diet    high-fat diet LGXSM w/par 16 both 20-30wks N=8 2004
    Cheverud1 17832 fat pad weights high-fat diet inquinal fat pad weight as pecent of body weight   [%]     control diet    high-fat diet LGXSM w/par 16 both 20-30wks N=8 2004
    Cheverud1 17833 fat pad weights high-fat diet total fat pad weight as pecent of body weight   [%]     control diet    high-fat diet LGXSM w/par 16 both 20-30wks N=8 2004
    Cheverud1 17840 hormone quantification high-fat diet insulin (serum)   [ng/mL]     control diet    high-fat diet LGXSM w/par 15 both 20-30wks N=8 2004
    Cheverud1 17841 hormone quantification high-fat diet leptin (serum)   [pg/mL]     control diet    high-fat diet LGXSM w/par 9 both 20-30wks N=6 2004
    Cheverud1 17842 lipid profile high-fat diet total cholesterol (serum CHOL)   [mg/dL]     control diet    high-fat diet LGXSM w/par 15 both 20-30wks N=8 2004
    Cheverud1 17843 lipid profile high-fat diet free fatty acid (serum FFA)   [mg/dL]     control diet    high-fat diet LGXSM w/par 15 both 20-30wks N=8 2004
    Cheverud1 17844 lipid profile high-fat diet triglycerides (serum TG, 4h fast)   [mg/dL]     control diet    high-fat diet LGXSM w/par 15 both 20-30wks N=8 2004
    Cheverud1 17845 glucose tolerance high-fat diet glucose levels, area under curve, glucose tolerance test (serum GLU, 10% glucose i.p., 4h fast)   [AUC]     control diet    high-fat diet LGXSM w/par 16 both 10wks N=8 2004
    Cheverud1 17846 glucose tolerance high-fat diet glucose levels, area under curve, glucose tolerance test (serum GLU, 10% glucose i.p., 4h fast)   [AUC]     control diet    high-fat diet LGXSM w/par 15 both 20wks N=8 2004
    Gavras1 14401 tail cuff sodium chloride systolic blood pressure   [mmHg]     control    NaCl inbred 9 both 9-12wks N=6 2003
    Gavras1 14403 tail cuff sodium chloride pulse rate   [n/min]     control    NaCl inbred 8 both 9-12wks N=7 2003
    Gershenfeld1 16210 light-dark box imipramine number of transitions between light and dark compartments in 10 min   [n]     baseline    imipramine 30mg/kg inbred 12 m 5-10wks N=5 2003
    Gershenfeld1 16212 open field test imipramine distance traveled in 5 min   [cm]     baseline    imipramine 30mg/kg inbred 12 m 5-10wks N=5 2003
    Gershenfeld1 16214 open field test imipramine vertical movements (rearing) in 15 min   [n]     baseline    imipramine 30mg/kg inbred 12 m 5-10wks N=5 2003
    Gershenfeld1 16216 open field test imipramine average center time, 2 trials   [s]     baseline    imipramine 30mg/kg inbred 12 m 5-10wks N=5 2003
    Gershenfeld1 16218 open field test imipramine number of fecal boli in 15 min   [n]     baseline    imipramine 30mg/kg inbred 12 m 5-10wks N=5 2003
    Gould2 47111 behavior observation nicotine chronic group: grooming   [n]     control    nicotine inbred 8 m 8-12wks N=10 2011
    Gould2 47113 behavior observation nicotine chronic group: scratching   [n]     control    nicotine inbred 8 m 8-12wks N=10 2011
    Gould2 47115 behavior observation nicotine chronic group: jumping   [n]     control    nicotine inbred 8 m 8-12wks N=10 2011
    Gould2 47121 elevated plus maze nicotine chronic group: time in closed arms   [%]     control    nicotine inbred 8 m 8-12wks N=9 2011
    Gould2 47123 elevated plus maze nicotine chronic group: time in open arms   [%]     control    nicotine inbred 8 m 8-12wks N=9 2011
    Gould2 47125 elevated plus maze nicotine chronic group: time in center   [%]     control    nicotine inbred 8 m 8-12wks N=9 2011
    Gould2 47151 fear conditioning test nicotine chronic group, conditioning: immediate fear   [%]     control    nicotine inbred 8 m 8-12wks N=10 2011
    Gould2 47156 fear conditioning test nicotine chronic group, conditioning: contextual fear   [%]     control    nicotine inbred 8 m 8-12wks N=10 2011
    Gould2 47161 fear conditioning test nicotine chronic group, cued fear: pre-cue   [%]     control    nicotine inbred 8 m 8-12wks N=10 2011
    Gould2 47166 fear conditioning test nicotine chronic group, cued fear: cue   [%]     control    nicotine inbred 8 m 8-12wks N=10 2011
    Gould4 54701 conditioned place preference test nicotine preference trial 1   [s]     control    nicotine inbred 8 m 8-10wks N=9 2014
    Gould4 54711 conditioned place preference test nicotine preference trial 2   [s]     control    nicotine inbred 8 m 8-10wks N=9 2014
    Graubert1 11616 histopathology ENU lung adenoma frequency rate   [score]     control    ENU inbred 20 both 13-68wks N=6 2006
    Graubert1 11617 histopathology ENU lung carcinoma frequency rate   [score]     control    ENU inbred 20 both 13-68wks N=6 2006
    Graubert1 11618 histopathology ENU lymphoid tumor frequency rate   [score]     control    ENU inbred 20 both 13-68wks N=6 2006
    Graubert1 11619 histopathology ENU myeloid tumor frequency rate   [score]     control    ENU inbred 20 both 13-68wks N=6 2006
    Graubert1 11620 histopathology ENU gastrointestinal (GI) tumor frequency rate   [score]     control    ENU inbred 20 both 13-68wks N=6 2006
    Harrill1 39501 body weight (none) body weight day 1   [g]     control group    treatment group inbred 34 f 8-10wks N=4 2011
    Harrill1 39503 body weight isoniazid body weight day 4   [g]     control    isoniazid inbred 33 f 8-10wks N=4 2011
    Harrill1 39505 organ weights isoniazid liver weight   [g]     control    isoniazid inbred 34 f 8-10wks N=4 2011
    Harrill1 39507 organ weights isoniazid liver weight as percent of body weight   [%]     control    isoniazid inbred 34 f 8-10wks N=4 2011
    Harrill1 39511 organ weights isoniazid spleen weight   [g]     control    isoniazid inbred 34 f 8-10wks N=4 2011
    Harrill1 39513 organ weights isoniazid spleen weight as percent of body weight   [%]     control    isoniazid inbred 34 f 8-10wks N=4 2011
    Harrill1 39521 metabolic panel isoniazid alanine transaminase (serum ALT)   [IU/L]     control    isoniazid inbred 34 f 8-10wks N=4 2011
    Harrill1 39526 lipid profile isoniazid hepatic cholesterol (CHOL)   [mg/dL]     control    isoniazid inbred 34 f 8-10wks N=4 2011
    Harrill1 39531 lipid profile isoniazid hepatic triglycerides (TG)   [mg/dL]     control    isoniazid inbred 34 f 8-10wks N=4 2011
    Harrill1 39541 histopathology isoniazid lymphohistiocytic, portal, multifocal infiltrate   [score]     control    isoniazid inbred 34 f 8-10wks N=4 2011
    Harrill1 39546 histopathology isoniazid hepatocytic cytoplasmic, microvesiculation, multifocal   [score]     control    isoniazid inbred 34 f 8-10wks N=4 2011
    Harrill1 39551 histopathology isoniazid hepatocytic cytoplasmic, microvesiculation, diffuse   [score]     control    isoniazid inbred 34 f 8-10wks N=4 2011
    Harrill1 39556 histopathology isoniazid hepatocytic hypertrophy, panlobular, diffuse   [score]     control    isoniazid inbred 34 f 8-10wks N=4 2011
    Harrill2 44101 body weight DB289 body weight at start of testing   [g]     control    DB289 inbred 34 f 6-8wks N=5 2012
    Harrill2 44103 body weight DB289 body weight at end of testing   [g]     control    DB289 inbred 34 f 6-8wks N=5 2012
    Harrill2 44105 body weight DB289 fold change in body weight over testing period   [ratio]     control    DB289    difference inbred 34 f 6-8wks N=5 2012
    Harrill2 44111 metabolic panel DB289 alanine transaminase (serum ALT)   [IU/L]     control    DB289    difference inbred 34 f 6-8wks N=5 2012
    Harrill2 44115 metabolic panel DB289 blood urea nitrogen (serum BUN)   [mg/dL]     control    DB289    difference inbred 34 f 6-8wks N=5 2012
    Harrill2 44121 metabolic panel DB289 creatinine (serum CREA)   [mg/dL]     control    DB289    difference inbred 34 f 6-8wks N=5 2012
    Harrill2 44125 urinalysis DB289 urine volume   [mL]     control    DB289    difference inbred 33 f 6-8wks N=5 2012
    Harrill2 44131 urinalysis DB289 creatinine (urine CREA)   [mg/mL]     control    DB289    difference inbred 31 f 6-8wks N=5 2012
    Harrill2 44135 biomarker quantification DB289 urine kidney injury molecule 1 (KIM-1)   [pg]     control    DB289    difference inbred 32 f 6-8wks N=5 2012
    Harrill2 44141 organ weights DB289 kidney (left) weight   [g]     control    DB289 inbred 34 f 6-8wks N=5 2012
    Harrill2 44144 organ weights DB289 kidney (right) weight   [g]     control    DB289 inbred 34 f 6-8wks N=5 2012
    Harrill2 44148 organ weights DB289 kidney (both) weight   [g]     control    DB289 inbred 34 f 6-8wks N=5 2012
    Harrill2 44151 organ weights DB289 total kidney weight as percent of body weight   [%]     control    DB289    difference inbred 34 f 6-8wks N=5 2012
    Harrill2 44155 drug and metabolite quantification DB289 kidney metabolite (DB75) concentration   [µM]     control    DB289 inbred 23 f 6-8wks N=4 2012
    Harrill2 44161 organ weights DB289 liver weight at sacrifice   [g]     control    DB289 inbred 34 f 6-8wks N=5 2012
    Harrill2 44165 organ weights DB289 liver weight as percent of body weight   [%]     control    DB289    difference inbred 34 f 6-8wks N=5 2012
    Lionikas1 48501 body weight exercise body weight at start of testing   [g]     control    exercise inbred 6 m 11-14wks N=15 2012
    Lionikas1 48502 body weight exercise body weight after 1 wk of testing   [g]     control    exercise inbred 6 m 11-14wks N=15 2012
    Lionikas1 48503 body weight exercise body weight after 2 wks of testing   [g]     control    exercise inbred 6 m 11-14wks N=15 2012
    Lionikas1 48504 body weight exercise body weight after 3 wks of testing   [g]     control    exercise inbred 6 m 11-14wks N=15 2012
    Lionikas1 48505 body weight exercise body weight after 4 wks of testing   [g]     control    exercise inbred 6 m 11-14wks N=15 2012
    Lionikas1 48506 body weight exercise body weight after 5 wks of testing   [g]     control    exercise inbred 6 m 11-14wks N=15 2012
    Lionikas1 48507 swim endurance test exercise duration of endurance swimming test   [min]     control    exercise inbred 6 m 11-14wks N=8 2012
    Lionikas1 48509 organ weights exercise weight of cardiac ventricles   [g]     control    exercise inbred 6 m 11-14wks N=15 2012
    Lionikas1 48510 bone dimensions exercise length of femur   [mm]     control    exercise inbred 6 m 11-14wks N=15 2012
    Lionikas1 48511 muscle weights exercise weight of tibialis anterior muscle   [g]     control    exercise inbred 6 m 11-14wks N=15 2012
    Lionikas1 48512 muscle weights exercise weight of extensor digitorum longus muscle   [g]     control    exercise inbred 6 m 11-14wks N=15 2012
    Lionikas1 48513 muscle weights exercise weight of gastrocnemius muscle   [g]     control    exercise inbred 6 m 11-14wks N=15 2012
    Lionikas1 48514 muscle weights exercise weight of quadriceps femoris muscle   [g]     control    exercise inbred 6 m 11-14wks N=15 2012
    Lionikas1 48515 muscle weights exercise weight of soleus muscle   [g]     control    exercise inbred 6 m 11-14wks N=15 2012
    Lionikas1 48516 microscopy exercise cross-sectional area of type I fibers of soleus muscle   [µm2]     control    exercise inbred 6 m 11-14wks N=6 2012
    Lionikas1 48517 microscopy exercise cross-sectional area of type IIa fibers of soleus muscle   [µm2]     control    exercise inbred 6 m 11-14wks N=6 2012
    Lionikas1 48518 microscopy exercise total number of fibers of soleus muscle   [n]     control    exercise inbred 6 m 11-14wks N=6 2012
    Lionikas1 48519 microscopy exercise number of type I fibers of soleus muscle   [n]     control    exercise inbred 6 m 11-14wks N=6 2012
    Lionikas1 48520 microscopy exercise number of type IIa fibers of soleus muscle   [n]     control    exercise inbred 6 m 11-14wks N=6 2012
    Lionikas1 48521 microscopy exercise number of intermediate fibers of soleus muscle   [n]     control    exercise inbred 6 m 11-14wks N=6 2012
    Lionikas1 48522 protein activity assessment exercise citrate synthase activity of gastrocnemius muscle   [U/g]     control    exercise inbred 6 m 11-14wks N=8 2012
    Lionikas1 48523 protein activity assessment exercise β-hydroxyacyl-CoA dehydrogenase activity of gastrocnemius muscle   [U/g]     control    exercise inbred 6 m 11-14wks N=8 2012
    Metten2 19503 behavior observation ethanol peak handling-induced convulsion (HIC) score   [score]     control    ethanol    ethanol normalized to controls inbred 15 m 8-15wks N=10 2005
    Morgan1 52613 body weight high-fat diet percent change in body weight, age 10wks vs. 8wks   [%]     age 10wks:    control    treated inbred w/CC8 9 f 10wks N=4 2014
    Morgan1 52615 body weight high-fat diet percent change in body weight, age 12wks vs. 8wks   [%]     age 12wks:    control    treated inbred w/CC8 9 f N=4 2014
    Morgan1 52617 body weight high-fat diet percent change in body weight, age 14wks vs. 8wks   [%]     age 14wks:    control    treated inbred w/CC8 9 f N=4 2014
    Morgan1 52619 body weight high-fat diet percent change in body weight, age 16wks vs. 8wks   [%]     age 16wks:    control    treated inbred w/CC8 9 f N=4 2014
    Morgan1 52621 body weight high-fat diet percent change in body weight, age 18wks vs. 8wks   [%]     age 18wks:    control    treated inbred w/CC7 8 f N=4 2014
    Nelson1 34101 body weight restricted diet body weight   [g]     control    DR diet ILSXISS 41 both 65-74wks N=4 2010
    Nelson1 34103 NMR restricted diet lean tissue mass, head included   [g]     control    DR diet ILSXISS 41 both 65-74wks N=4 2010
    Nelson1 34105 NMR restricted diet fat tissue mass, head included   [g]     control    DR diet ILSXISS 41 both 65-74wks N=4 2010
    Nelson1 34107 NMR restricted diet percent fat, whole body with head   [%]     control    DR diet ILSXISS 41 both 65-74wks N=4 2010
    Nelson1 34109 colony observation restricted diet lifespan   [d]     control    DR diet ILSXISS 41 both varies N=5 2010
    Rhodes1 34601 running wheel monitoring exercise locomotor activity   [km/d]     control    with running wheel inbred 12 both 8-15wks N=4 2010
    Rhodes1 34603 microscopy exercise hippocampus: volume of dentate gyrus   [mm3]     control    with running wheel inbred 12 both 15wks N=4 2010
    Rhodes1 34605 microscopy exercise hippocampus: number of new neurons in dentate gyrus   [n]     control    with running wheel inbred 12 both 15wks N=4 2010
    Rhodes1 34607 microscopy exercise hippocampus: density of new neurons in dentate gyrus   [n/mm3]     control    with running wheel inbred 12 both 15wks N=4 2010
    Rhodes1 34609 body weight exercise final body weight   [g]     control    with running wheel inbred 12 both 15wks N=4 2010
    Rhodes1 34611 body weight exercise change in body weight   [ratio]     control    with running wheel inbred 12 both 15wks N=4 2010
    Rusyn5 43001 metabolic panel high-fat diet and ethanol serum alanine transaminase (ALT)   [IU/L]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43003 metabolite quantification high-fat diet and ethanol homocysteine concentration (plasma)   [nmol/mL]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43005 alcohol quantification high-fat diet and ethanol blood alcohol concentration (BAC)   [mg/dL]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43007 alcohol quantification high-fat diet and ethanol urine alcohol concentration (UAC), daily average   [mg/dL]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43009 alcohol quantification high-fat diet and ethanol urine alcohol concentration (UAC), daily peak   [mg/dL]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43011 organ weights high-fat diet and ethanol liver weight as a percent of body weight   [%]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43013 histopathology high-fat diet and ethanol liver steatosis (0-4)   [score]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43015 histopathology high-fat diet and ethanol liver inflammation (0-2)   [score]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43017 histopathology high-fat diet and ethanol liver necrosis (0-2)   [score]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43019 histopathology high-fat diet and ethanol total liver histopathology (0-8)   [score]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43021 lipid profile high-fat diet and ethanol hepatic triglycerides (TG)   [mg/g]     high-fat only    high-fat and ethanol inbred 6 m 8-14wks N=3 2011
    Rusyn5 43023 metabolite quantification high-fat diet and ethanol reduced liver glutathione (GSH)   [nmol/mg]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43025 metabolite quantification high-fat diet and ethanol oxidized liver glutathione (GSSG)   [nmol/mg]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43029 metabolite quantification high-fat diet and ethanol ratio of reduced to oxidized liver glutathione   [ratio]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43031 metabolite quantification high-fat diet and ethanol liver homocysteine   [nmol/mg]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43033 metabolite quantification high-fat diet and ethanol liver S-adenosylhomocysteine (SAH)   [nmol/mg]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43035 metabolite quantification high-fat diet and ethanol liver methionine   [nmol/mg]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43037 metabolite quantification high-fat diet and ethanol liver S-adenosylmethionine (SAM)   [nmol/mg]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn5 43039 metabolite quantification high-fat diet and ethanol ratio of liver SAM to SAH (SAM/SAH)   [ratio]     high-fat only    high-fat and ethanol inbred 14 m 8-14wks N=3 2011
    Rusyn6 51209 metabolic panel trichloroethylene blood urea nitrogen (serum BUN)   [mg/dL]     control    TCE inbred 7 m 6-7wks N=4 2014
    Rusyn6 51211 organ weights trichloroethylene liver weight as a percent of body weight   [%]     control    TCE inbred 7 m 6-7wks N=4 2014
    Rusyn6 51251 organ weights trichloroethylene kidney weight as a percent of body weight   [%]     control    TCE inbred 7 m 6-7wks N=4 2014
    Rusyn6 51255 histopathology trichloroethylene kidney injury molecule 1 (KIM-1) positive proximal tubules   [%]     control    TCE inbred 7 m 6-7wks N=4 2014
    Schwartz2 9801 bronchoalveolar lavage assessment ovalbumin alveolar eosinophils (percent of total lavage cells), pre-challenge   [%]     pre-test:    control    OVA-sensitized inbred 8 m 6-8wks N=3 2001
    Schwartz2 9802 bronchoalveolar lavage assessment ovalbumin alveolar eosinophils (percent of total lavage cells), 24h post-challenge   [%]     24h post:    control    OVA-sensitized inbred 8 m 6-8wks N=5 2001
    Schwartz2 9803 bronchoalveolar lavage assessment ovalbumin alveolar eosinophils (percent of total lavage cells), 48h post-challenge   [%]     48h post:    control    OVA-sensitized inbred 8 m 6-8wks N=5 2001
    Schwartz2 9804 bronchoalveolar lavage assessment ovalbumin alveolar eosinophils (percent of total lavage cells), 72h post-challenge   [%]     72h post:    control    OVA-sensitized inbred 8 m 6-8wks N=5 2001
    Schwartz2 9821 bronchoalveolar lavage assessment ovalbumin alveolar lymphocytes (percent of total lavage cells), pre-challenge   [%]     pre-test:    control    OVA-sensitized inbred 8 m 6-8wks N=3 2001
    Schwartz2 9822 bronchoalveolar lavage assessment ovalbumin alveolar lymphocytes (percent of total lavage cells), 24h post-challenge   [%]     24h post:    control    OVA-sensitized inbred 8 m 6-8wks N=5 2001
    Schwartz2 9823 bronchoalveolar lavage assessment ovalbumin alveolar lymphocytes (percent of total lavage cells), 48h post-challenge   [%]     48h post:    control    OVA-sensitized inbred 8 m 6-8wks N=5 2001
    Schwartz2 9824 bronchoalveolar lavage assessment ovalbumin alveolar lymphocytes (percent of total lavage cells), 72h post-challenge   [%]     72h post:    control    OVA-sensitized inbred 8 m 6-8wks N=5 2001
    Schwartz2 9841 bronchoalveolar lavage assessment ovalbumin alveolar neutrophils (percent of total lavage cells), pre-challenge   [%]     pre-test:    control    OVA-sensitized inbred 8 m 6-8wks N=3 2001
    Schwartz2 9842 bronchoalveolar lavage assessment ovalbumin alveolar neutrophils (percent of total lavage cells), 24h post-challenge   [%]     24h post:    control    OVA-sensitized inbred 8 m 6-8wks N=5 2001
    Schwartz2 9843 bronchoalveolar lavage assessment ovalbumin alveolar neutrophils (percent of total lavage cells), 48h post-challenge   [%]     48h post:    control    OVA-sensitized inbred 8 m 6-8wks N=5 2001
    Schwartz2 9844 bronchoalveolar lavage assessment ovalbumin alveolar neutrophils (percent of total lavage cells), 72h post-challenge   [%]     72h post:    control    OVA-sensitized inbred 8 m 6-8wks N=5 2001
    Shockley1 33401 body weight high-fat diet body weight   [g]     control diet    high-fat diet    difference inbred 10 both 10-13wks N=5 2008
    Shockley1 33402 metabolic panel high-fat diet blood urea nitrogen (BUN)   [mg/dL]     control diet    high-fat diet    difference inbred 10 both 10-13wks N=4 2008
    Shockley1 33403 metabolic panel high-fat diet calcium (Ca)   [mg/dL]     control diet    high-fat diet    difference inbred 10 both 10-13wks N=5 2008
    Shockley1 33404 metabolic panel high-fat diet glutamate dehydrogenase (GLDH)   [IU/L]     control diet    high-fat diet    difference inbred 10 both 10-13wks N=5 2008
    Shockley1 33405 metabolic panel high-fat diet glucose (GLU, 4h fast)   [mg/dL]     control diet    high-fat diet    difference inbred 10 both 10-13wks N=5 2008
    Shockley1 33406 lipid profile high-fat diet total cholesterol (CHOL)   [mg/dL]     control diet    high-fat diet    difference inbred 10 both 10-13wks N=5 2008
    Shockley1 33407 lipid profile high-fat diet HDL cholesterol (HDL)   [mg/dL]     control diet    high-fat diet    difference inbred 10 both 10-13wks N=5 2008
    Shockley1 33408 lipid profile high-fat diet nonesterified fatty acid (NEFA)   [mEq/L]     control diet    high-fat diet    difference inbred 10 both 10-13wks N=5 2008
    Shockley1 33409 lipid profile high-fat diet triglycerides (TG, 5h fast)   [mg/dL]     control diet    high-fat diet    difference inbred 10 both 10-13wks N=5 2008
    Shockley1 33410 metabolic panel high-fat diet thyroxine (T4)   [µg/dL]     control diet    high-fat diet    difference inbred 10 both 10-13wks N=5 2008
    Tarantino2 50601 open field test ovariectomy distance   [cm]     control    ovariectomy inbred 37 f 10-12wks N=9 2016
    Tarantino2 50606 open field test ovariectomy time mobile   [s]     control    ovariectomy inbred 37 f 10-12wks N=9 2016
    Tarantino2 50611 open field test ovariectomy vertical   [n]     control    ovariectomy inbred 37 f 10-12wks N=9 2016
    Tarantino2 50616 open field test ovariectomy center distance   [cm]     control    ovariectomy inbred 37 f 10-12wks N=9 2016
    Tarantino2 50621 open field test ovariectomy center duration   [s]     control    ovariectomy inbred 37 f 10-12wks N=9 2016
    Tarantino2 50626 open field test ovariectomy percent center duration   [%]     control    ovariectomy inbred 37 f 10-12wks N=9 2016
    Tarantino2 50631 open field test ovariectomy thigmotaxis   [cm]     control    ovariectomy inbred 37 f 10-12wks N=9 2016
    Tarantino2 50636 forced swim test ovariectomy percent immobility   [%]     control    ovariectomy inbred 36 f 10-12wks N=9 2016
    Threadgill1 19414 metabolite quantification acetaminophen reduced glutathione (GSH)   [µmol/g]     control    post-Rx 300mg/kg inbred w/CC7 35 m 8-17wks N=3 2005
    Threadgill1 19416 metabolite quantification acetaminophen oxidized glutathione (GSSG)   [µmol/g]     control    post-Rx 300mg/kg inbred w/CC7 35 m 8-17wks N=3 2005
    Threadgill1 19418 metabolite quantification acetaminophen total glutathione (GSH plus GSSG)   [µmol/g]     control    post-Rx 300 mg/kg inbred w/CC7 35 m 8-17wks N=3 2005
    Threadgill1 19420 metabolite quantification acetaminophen ratio of reduced (GSH) to oxidized (GSSG) glutathione   [ratio]     control    post-Rx 300mg/kg inbred w/CC7 35 m 8-17wks N=3 2005
    Threadgill1 19482 metabolic panel acetaminophen catalase   [µg/mL]     control    post-Rx 300 mg/kg inbred w/CC7 37 m 8-12wks N=3 2005
    Threadgill1 19483 biomarker quantification acetaminophen cytochrome P450 1A2 isoform   [pmol/mg]     control    post-Rx 300 mg/kg inbred 36 m 8-12wks N=3 2005
    Threadgill1 19484 biomarker quantification acetaminophen cytochrome P450 2E1 isoform   [pmol/mg]     control    post-Rx 300 mg/kg inbred w/CC7 37 m 8-12wks N=3 2005
    Threadgill1 19486 metabolite quantification acetaminophen glutathione transferase   [µg/mL]     control    post-Rx 300 mg/kg inbred w/CC7 37 m 8-12wks N=3 2005
    Threadgill2 39605 metabolite quantification acetaminophen reduced glutathione (GSH)   [µmol/mg]     control    post-Rx 300 mg/kg inbred 5 m 6-8wks N=4 2005
    Threadgill2 39606 metabolite quantification acetaminophen percent reduced glutathione   [%]     control    post-Rx 300 mg/kg inbred 5 m 6-8wks N=4 2005
    Threadgill2 39607 metabolite quantification acetaminophen total glutathione   [µmol/mg]     control    post-Rx 300 mg/kg inbred 5 m 6-8wks N=4 2005
    Wiltshire2 38001 tail suspension test fluoxetine TST duration of immobility   [%]     control    fluoxetine inbred 30 m 9-10wks N=10 2011
    Wiltshire2 38003 open field test fluoxetine OFT center avoidance (thigmotaxis)   [%]     control    fluoxetine inbred 30 m 10-11wks N=11 2011
    Wiltshire2 38005 open field test fluoxetine OFT distance traveled   [cm]     control    fluoxetine inbred 30 m 10-11wks N=11 2011
    Wiltshire2 38007 drug and metabolite quantification fluoxetine drug and metabolite concentration   [ng/mL]     fluoxetine    norfluoxetine inbred 30 m 10-11wks N=11 2011
    Wiltshire3 38101 biomarker quantification fluoxetine ACTH     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38104 biomarker quantification fluoxetine APOD     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38107 biomarker quantification fluoxetine BAG1     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38110 biomarker quantification fluoxetine BDNF     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38113 biomarker quantification fluoxetine CREB1 (CREB)     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38116 biomarker quantification fluoxetine FOS (c-fos)     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38119 biomarker quantification fluoxetine FUT9     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38122 biomarker quantification fluoxetine GAD1 (GAD67)     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38125 biomarker quantification fluoxetine GAL     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38128 biomarker quantification fluoxetine GFAP     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38131 biomarker quantification fluoxetine GHRL     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38134 biomarker quantification fluoxetine GIRK3 (KCNJ9)     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38137 biomarker quantification fluoxetine GLO1     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38140 biomarker quantification fluoxetine GNB1     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38143 biomarker quantification fluoxetine GRIN1 (NMDA1)     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38146 biomarker quantification fluoxetine GSK3B     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38149 biomarker quantification fluoxetine GSR     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38152 biomarker quantification fluoxetine HDAC5     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38155 biomarker quantification fluoxetine NGF     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38158 biomarker quantification fluoxetine NPY     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38161 biomarker quantification fluoxetine P2RX7 (P2X7)     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38164 biomarker quantification fluoxetine PAQR8     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38167 biomarker quantification fluoxetine PPP1R1B     control    fluoxetine inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38170 biomarker quantification fluoxetine PTH     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38173 biomarker quantification fluoxetine S100B     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38176 biomarker quantification fluoxetine SCG5 (SGNE)     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38179 biomarker quantification fluoxetine SLC6A2 (NET)     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38182 biomarker quantification fluoxetine SLC6A4 (SERT)     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38185 biomarker quantification fluoxetine SST     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38188 biomarker quantification fluoxetine TNF (TNFa)     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    Wiltshire3 38191 biomarker quantification fluoxetine VEGFA (VEGF)     control    fluoxetine    change index inbred 30 m 10-11wks N=3 2011
    All boxes             To see more rows use the paging control at top.